Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

4.5%

1 terminated/withdrawn out of 22 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
21(95.5%)
N/A
1(4.5%)
22Total
Phase 1(21)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (22)

Showing 20 of 22 trials
NCT04584437Not ApplicableWithdrawn

Treatment of Covid-19 Infections Using Vitality Therapy or the Bible Cure

Role: lead

NCT00574106Phase 1Unknown

A Study to Evaluate the Effect of Far Infrared Radiation for Cancer Treatment

Role: lead

NCT00673140Phase 1Unknown

Far Infrared Irradiation for Control, Management and Treatment of Amyotrophic Lateral Sclerosis (ALS)

Role: lead

NCT00574522Phase 1Unknown

Energy Specific Far Infrared Radiation Treatment for AIDS

Role: lead

NCT00573820Phase 1Unknown

Far Infrared Radiation Treatment for Prostate Cancer

Role: lead

NCT00573456Phase 1Unknown

Far Infrared Radiation Treatment for Diabetes

Role: lead

NCT00573209Phase 1Unknown

Energy Specific Far Infrared Radiation Treatment for Erectile Dysfunction

Role: lead

NCT00674960Phase 1Unknown

Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia

Role: lead

NCT00574054Phase 1Unknown

Far Infrared Radiation Treatment of Dementia and Other Mental Illness

Role: lead

NCT00573196Phase 1Unknown

Far Infrared Radiation Treatment for Bipolar Condition

Role: lead

NCT00599469Phase 1Unknown

Far Infrared Treatment for Alzheimer's Disease

Role: lead

NCT00674843Phase 1Unknown

The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies

Role: lead

NCT00573573Phase 1Unknown

Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism

Role: lead

NCT00674895Phase 1Unknown

Far Infrared Irradiation for Management and Treating of Parkinson's Disease (PD)

Role: lead

NCT00675155Phase 1Unknown

Far Infrared Irradiation for Stroke Rehabilitation

Role: lead

NCT00674934Phase 1Unknown

Far Infrared Irradiation for Managing and Treating Multiple Sclerosis (MS)

Role: lead

NCT00573807Phase 1Unknown

Energy Specific Far Infrared Radiation Treatment for Sciatica

Role: lead

NCT00573352Phase 1Unknown

Far Infrared Radiation Treatment for Osteoarthritis

Role: lead

NCT00599391Phase 1Unknown

Far Infrared Treatment for Kidney Diseases

Role: lead

NCT00675077Phase 1Unknown

Far Infrared Irradiation for Managing, Control and Treatment of Huntington's Disease (HD)

Role: lead